LINQ PHARMA CONSULTING, INC.
DEAD

Serial Number

98453025

Owner

Linq Pharma Consulting, Inc.

First Use Date

Apr 7, 2015

Filing Date

Mar 16, 2024

Add to watchlist:

No watchlists yet
View on USPTO

LINQ PHARMA CONSULTING, INC. Trademark

Serial Number: 98453025

LINQ PHARMA CONSULTING, INC. is a trademark filed by Linq Pharma Consulting, Inc. on March 16, 2024. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services). The application is currently no longer active.

Owner Contact Info

Linq Pharma Consulting, Inc.

Suite 120-212
Aldie, VA 20105

Entity Type: 03

Trademark Details

Filing Date

March 16, 2024

Registration Date

Not Registered

First Use Anywhere

April 7, 2015

First Use in Commerce

April 7, 2015

Goods & Services

Regulatory compliance consultancy in the field of pharmaceuticals; Regulatory compliance consulting in the field of pharmaceuticals

Medical and pharmaceutical consultation

Consulting services in the field of pharmaceutical research; Consulting services in the field of pharmaceutical research and development; Technical consulting in the field of pharmaceutical studies

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Feb 8, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Feb 8, 2025 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 25, 2024 GNRN
NON-FINAL ACTION E-MAILED
Sep 25, 2024 GNRT
NON-FINAL ACTION WRITTEN
Sep 25, 2024 CNRT
ASSIGNED TO EXAMINER
Sep 25, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 21, 2024 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 11, 2024 NWOS
NEW APPLICATION ENTERED
Mar 16, 2024 NWAP